Biotechnology, Pharmaceutical and Life Science Reports and Courses

Main Pages

Best Selling Products

BioNewsCast Press Release Distribution Service

Bioinformatics Market Potential

Vaccine Research & Development 2009

Veterinary Diagnostics Markets

Practical Guide to Finding Partners in Pharma & Biotech, 2nd edition

New Products

Advanced Wound Management Pipeline Technology and Market Forecasts to 2015

Artificial Disc Replacement Pipeline Technology and Market Forecasts to 2015

Brazil Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Brazil Orthopedic Devices Market Analysis and Forecasts to 2015

Canada Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015

Canada Diabetes Care Devices Market Analysis and Forecasts to 2015

Canada Medical Equipment Market Analysis and Forecasts to 2015

Cardiac Assist Devices Pipeline Technology and Market Forecasts to 2015

China Medical Equipment Market Analysis and Forecasts to 2015

Chronic Diseases on the Rise: Personal Health Systems to Play a Key Role in Disease Management

BioPortfolio | CuttingEdgeInfo Reports | Clinical Outsourcing Strategy

Selecting Partners and Managing Relationships (PH125)

Clinical Outsourcing Strategy Selecting Partners and Managing Relationships (PH125)

Perfect the CRO selection and management process - and guarantee trial success

Clinical Outsourcing Strategy: Selecting Partners and Managing Relationships will guide your company to adopt a proactive approach to avoiding common pitfalls in the clinical trial process. It identifies key questions every trial sponsor should consider before engaging with a client, such as: How does patient recruitment fit into outsourcing strategy? Does this CRO have a reputation for meeting deadlines? Will this CRO's size allow it to meet my needs for a trial?

Use this report to navigate confidently through the CRO selection and management process:

* Determine which factors to weigh when developing outsourcing strategy

* Base vendor selection upon CRO criteria and rankings

* Understand the advantages and risks of outsourcing to international sites

* Accelerate and streamline the CRO selection timeline/process

...and more!

Outsourcing is a powerful option for achieving clinical objectives, allowing pharma companies to expand their reach in a therapeutic area, leverage vendors' expertise, and usher a drug through development smoothly - all without overburdening resources.

With such benefits come giant obstacles, however. If managed poorly, clinical outsourcing can cause pharma companies to scramble around, regretting decisions and reacting constantly to problems such as trial under-enrollment, numerous change orders, and weak oversight. CRO management problems can also lead to trial overruns - resulting in hundreds of thousands of dollars wasted and an uncertain market future for a drug. Hitting some snags in the clinical process is unavoidable, but this scenario is the exact opposite of what clinical outsourcing is aimed to solve.

Companies Included in Report

* Abraxis

* Allergan

* ARIAD Pharmaceuticals

* AstraZeneca

* BAROnova

* Ipsen

* Isis Pharmaceuticals

* Johnson & Johnson

* Matrix Clinical Research Management

* Medarex

* Needham & Company

* Novartis Consumer Health

* Novo Nordisk

* Nycomed

* Schering-Plough

* Shire Pharmaceuticals

* Stromedix

* Wyeth

* Several smaller drug companies, consultancies and CRO experts also contributed to this research.

Published 2009

90 Pages

200+ Metrics

34 Charts and Diagrams

Table of Contents
Price: $7,695.00 / €5,143.34

BioPortfolio uses RBS Worldpay Secure Server for credit card transactions